Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
7 drugs in development
By Therapeutic Area
top 4
R&D Momentum
85/100
Pipeline Velocity
61/100
Trial Completion Rate
57/100
Pipeline Concentration
31/100
Pipeline Freshness
70/100
Strategic Signals
Activity
Last 14 days
DECIDE to Improve Maternal Mental Health Care Delivery
Evaluate and Compare the Effectiveness of a Novel Toothbrush, Ortho-Buddy, Designed Specifically for Patients Undergoing Orthodontic Treatment With a Standard Toothbrush
Modulating Neural Mechanisms of Reward Processing in Tobacco Users
SHORTened Duration of TAMoxifen for Risk Reduction in Breast Intraepithelial Neoplasms in Post-menopausal Women
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)